Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
J Hosp Infect ; 114: 63-78, 2021 Aug.
Article in English | MEDLINE | ID: covidwho-1317467

ABSTRACT

The ongoing pandemic of COVID-19 has underlined the importance of adopting effective infection prevention and control (IPC) measures in hospital and community settings. Ultraviolet (UV)-based technologies represent promising IPC tools: their effective application for sanitation has been extensively evaluated in the past but scant, heterogeneous and inconclusive evidence is available on their effect on SARS-CoV-2 transmission. With the aim of pooling the available evidence on the efficacy of UV technologies against coronaviruses, we conducted a systematic review following PRISMA guidelines, searching Medline, Embase and the Cochrane Library, and the main clinical trials' registries (WHO ICTRP, ClinicalTrials.gov, Cochrane and EU Clinical Trial Register). Quantitative data on studies' interventions were summarized in tables, pooled by different coronavirus species and strain, UV source, characteristics of UV light exposure and outcomes. Eighteen papers met our inclusion criteria, published between 1972 and 2020. Six focused on SARS-CoV-2, four on SARS-CoV-1, one on MERS-CoV, three on seasonal coronaviruses, and four on animal coronaviruses. All were experimental studies. Overall, despite wide heterogenicity within included studies, complete inactivation of coronaviruses on surfaces or aerosolized, including SARS-CoV-2, was reported to take a maximum exposure time of 15 min and to need a maximum distance from the UV emitter of up to 1 m. Advances in UV-based technologies in the field of sanitation and their proved high virucidal potential against SARS-CoV-2 support their use for IPC in hospital and community settings and their contribution towards ending the COVID-19 pandemic. National and international guidelines are to be updated and parameters and conditions of use need to be identified to ensure both efficacy and safety of UV technology application for effective infection prevention and control in both healthcare and non-healthcare settings.


Subject(s)
COVID-19 , Coronavirus/radiation effects , SARS-CoV-2/radiation effects , Ultraviolet Rays , Animals , COVID-19/prevention & control , Humans , Pandemics , Technology
2.
Photochem Photobiol ; 97(1): 213-220, 2021 01.
Article in English | MEDLINE | ID: covidwho-873410

ABSTRACT

The pandemic COVID-19 disease affects people dramatically overall the globe by illness and death. Several strategies are applied to restrict the spread of this disease such as lockdown, adequate social distance in different activities, hand disinfection and the use of masks. Potential hazard outdoors comes from released viruses, which may remain in the air for a while and settle down afterward and contaminating surfaces. Solar ultraviolet radiation (UVR) is known to act as a natural environmental virucide. The virucidal effectivity of UVR depends on a first order on the sensitivity of the virus against UVR as well as on the amount of incoming UVR. Here, we present estimates of the potential of solar UVR in inactivating SARS-CoV-2 in the environment. This is done by combining DNA-damaging surface solar UVR retrieved by satellites and the available information on fluence for inactivation of Coronaviridae. Our results show that solar UVR has a high potential to inactivate these viruses, but the degree depends strongly on location and season. In the subtropics (Sao Paulo, 23.5°S), the daily survival fraction is lower than 10-4 during the whole year, while close at norther latitudes (Reykjavik, 64°N), such a reduction can be found in June and July only.


Subject(s)
COVID-19/virology , Coronavirus/radiation effects , Sunlight , Ultraviolet Rays , COVID-19/epidemiology , SARS-CoV-2 , Seasons
SELECTION OF CITATIONS
SEARCH DETAIL